The company will also spotlight the Global Vision BraillePoint™ Braille dot height measurement tool. BraillePoint is designed to meet the European Standard BS EN 15823 2010 requirements for pharmaceutical companies, mandating that the name of the product be included in Braille on the packaging of authorized medication to aid identification.
As part of this initiative specific requirements have been imposed on the height and placement of the Braille dot in order to ensure easy readability for the visually impaired.
"With compliance requirements and new standards being particularly sensitive issues for European companies, Global Vision proofreading solutions are ideal for the growing pharmaceutical marketplace," explained Antonio D’Isep, President, A.M.D. Electronic.
"We at A.M.D. Electronic remain committed to the Italian market and Pharmintech offers us the perfect platform to directly address one of the fastest growing technology markets in the world as well as to interact with our current customers and key partners."